Latest Manufacturing Capacity News

Page 12 of 12
DroneShield Limited reports a 6.3% increase in 2024 revenue to $57.5 million, underpinned by a doubling of SaaS sales and a robust $1.2 billion sales pipeline heading into 2025.
Victor Sage
Victor Sage
29 Jan 2025
Bioxyne Limited has reported a remarkable 77% jump in revenue for Q2 FY2025, alongside positive operating cash flow, as it prepares to expand manufacturing capacity and enter new international markets.
Victor Sage
Victor Sage
28 Jan 2025
Bioxyne Limited reports a remarkable 77% revenue increase in Q2 FY2025 alongside positive operating cash flow, setting the stage for international growth with upcoming UK export approvals and a planned European GMP facility.
Victor Sage
Victor Sage
28 Jan 2025
IperionX has completed its inaugural end-to-end titanium powder production cycle using its proprietary HAMR process and secured exclusive rights to breakthrough titanium technologies, positioning itself for expanded manufacturing capacity and strong market demand.
Maxwell Dee
Maxwell Dee
28 Jan 2025
EBR Systems has signed a long-term lease for a 51,000 sq ft facility in Santa Clara, California, positioning itself for significant manufacturing expansion and future growth in wireless cardiac pacing technology.
Ada Torres
Ada Torres
28 Jan 2025
Telix Pharmaceuticals has finalized its acquisition of RLS (USA) Inc., significantly expanding its radiopharmaceutical footprint across the United States with a network of over 30 radiopharmacies.
Victor Sage
Victor Sage
28 Jan 2025
RLF AgTech Ltd has retracted previously announced field trial results due to ASX compliance issues, while simultaneously reporting significant debt reduction and ongoing equity raising efforts to support its expanding Australian and Chinese operations.
Ada Torres
Ada Torres
23 Jan 2025
Chrysos Corporation reports a robust Q2 FY25 with a 12% quarter-on-quarter and 53% year-on-year revenue increase, driven by expanding international sales and rising sample volumes. The company secured two new contracts, boosting its PhotonAssay™ footprint and maintaining strong financial health.
Maxwell Dee
Maxwell Dee
22 Jan 2025
Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.
Ada Torres
Ada Torres
14 Jan 2025
Syrah Resources has been awarded a US$165 million tax credit under the US Inflation Reduction Act to support the expansion of its Vidalia active anode material facility in Louisiana, potentially increasing production capacity to 45ktpa.
Maxwell Dee
Maxwell Dee
13 Jan 2025